These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 15126149

  • 1. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K, Fijnheer R, Rothova A.
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [Abstract] [Full Text] [Related]

  • 2. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
    Navarro S, Ricart JM, Medina P, Vayá A, Villa P, Todolí J, Estellés A, Micó ML, Aznar J, España F.
    Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E, Sadikoğlu B, Ertuğrul E, Beyan C.
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [Abstract] [Full Text] [Related]

  • 5. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B, Jacobs N, Mahieu S, Naelaerts K, Vertessen F, Weyler J, Jacquemyn Y, Van der Planken M.
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Plasma coagulation and fibrinolysis parameters in patients with vascular Behçet's disease, and analysis of the multimeric structure of von Willebrand factor (vWF)].
    Kagawa H, Okubo S.
    Ryumachi; 1993 Oct; 33(5):416-23. PubMed ID: 8256164
    [Abstract] [Full Text] [Related]

  • 12. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
    Kahn SR, Solymoss S, Flegel KM.
    CMAJ; 1997 Sep 15; 157(6):673-81. PubMed ID: 9307553
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Activated protein C resistance in Behçet disease].
    Guermazi S, M'Rad S, Lamloum M, Houman MH, Hamza M, Ben Dridi M, Miled M, Dellagi K.
    Pathol Biol (Paris); 1998 Dec 15; 46(10):791-5. PubMed ID: 9922996
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK, Chamberlain MA, Menon DK, Davies JA.
    Thromb Haemost; 1991 Sep 02; 66(3):292-4. PubMed ID: 1745999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 02; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 19. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G, Font J, Tàssies D, Vidaller A, Deulofeu R, López-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter JC.
    Am J Med; 2002 Jan 02; 112(1):37-43. PubMed ID: 11812405
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.